Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Idasanutlin + Ixazomib + Dexamethasone in Relapsed 17p-Deleted MM
NCT02633059Phase 2Completed
- Sponsor
- Mayo Clinic
- Start
- Dec 2015
- Primary completion
- Jan 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of idasanutlin in multiple myeloma (MM), sponsored by Mayo Clinic. Started Dec 2015; status: completed.
02
Drugs
idasanutlin
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT02633059.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02633059.